AU2002356763A1 - Use of a technically modified cell as a vaccine for treating tumoral disease - Google Patents

Use of a technically modified cell as a vaccine for treating tumoral disease

Info

Publication number
AU2002356763A1
AU2002356763A1 AU2002356763A AU2002356763A AU2002356763A1 AU 2002356763 A1 AU2002356763 A1 AU 2002356763A1 AU 2002356763 A AU2002356763 A AU 2002356763A AU 2002356763 A AU2002356763 A AU 2002356763A AU 2002356763 A1 AU2002356763 A1 AU 2002356763A1
Authority
AU
Australia
Prior art keywords
vaccine
modified cell
technically modified
tumoral disease
treating tumoral
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU2002356763A
Inventor
Claudia Breidenstein
Adelheid Dinkel
John Nieland
Ute Sartorius
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Medigene AG
Original Assignee
Medigene AG
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Medigene AG filed Critical Medigene AG
Publication of AU2002356763A1 publication Critical patent/AU2002356763A1/en
Abandoned legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/0005—Vertebrate antigens
    • A61K39/0011—Cancer antigens
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/0005—Vertebrate antigens
    • A61K39/0011—Cancer antigens
    • A61K39/001148—Regulators of development
    • A61K39/00115—Apoptosis related proteins, e.g. survivin or livin
    • A61K39/001151—Apoptosis related proteins, e.g. survivin or livin p53
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/0005—Vertebrate antigens
    • A61K39/0011—Cancer antigens
    • A61K39/00118—Cancer antigens from embryonic or fetal origin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/0005—Vertebrate antigens
    • A61K39/0011—Cancer antigens
    • A61K39/001184—Cancer testis antigens, e.g. SSX, BAGE, GAGE or SAGE
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/0005—Vertebrate antigens
    • A61K39/0011—Cancer antigens
    • A61K39/001184—Cancer testis antigens, e.g. SSX, BAGE, GAGE or SAGE
    • A61K39/001186—MAGE
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/0005—Vertebrate antigens
    • A61K39/0011—Cancer antigens
    • A61K39/001184—Cancer testis antigens, e.g. SSX, BAGE, GAGE or SAGE
    • A61K39/001188—NY-ESO
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/0005—Vertebrate antigens
    • A61K39/0011—Cancer antigens
    • A61K39/001184—Cancer testis antigens, e.g. SSX, BAGE, GAGE or SAGE
    • A61K39/001189—PRAME
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/0005—Vertebrate antigens
    • A61K39/0011—Cancer antigens
    • A61K39/00119—Melanoma antigens
    • A61K39/001192—Glycoprotein 100 [Gp100]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
    • A61K2039/515—Animal cells
    • A61K2039/5152—Tumor cells
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
    • A61K2039/515—Animal cells
    • A61K2039/5156—Animal cells expressing foreign proteins

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Microbiology (AREA)
  • Mycology (AREA)
  • Immunology (AREA)
  • Oncology (AREA)
  • Developmental Biology & Embryology (AREA)
  • Gynecology & Obstetrics (AREA)
  • Pregnancy & Childbirth (AREA)
  • Reproductive Health (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
AU2002356763A 2001-11-30 2002-11-29 Use of a technically modified cell as a vaccine for treating tumoral disease Abandoned AU2002356763A1 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US33449101P 2001-11-30 2001-11-30
US60/334,491 2001-11-30
PCT/EP2002/013531 WO2003045428A2 (en) 2001-11-30 2002-11-29 Use of a technically modified cell as a vaccine for treating tumoral disease

Publications (1)

Publication Number Publication Date
AU2002356763A1 true AU2002356763A1 (en) 2003-06-10

Family

ID=23307453

Family Applications (1)

Application Number Title Priority Date Filing Date
AU2002356763A Abandoned AU2002356763A1 (en) 2001-11-30 2002-11-29 Use of a technically modified cell as a vaccine for treating tumoral disease

Country Status (2)

Country Link
AU (1) AU2002356763A1 (en)
WO (1) WO2003045428A2 (en)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7956043B2 (en) 2002-12-11 2011-06-07 Coley Pharmaceutical Group, Inc. 5′ CpG nucleic acids and methods of use
DE10362104B4 (en) * 2003-08-29 2008-02-14 Kist-Europe Forschungsgesellschaft Mbh Cell processor for disease treatment
RU2354694C2 (en) * 2003-12-30 2009-05-10 Мологен Аг Allogeneic antitumor therapeutic medication
CN103245787B (en) * 2012-02-01 2016-01-20 浙江大学 A kind of preparation method of liver cancer derivative growth factor detection kit
EP3545001A4 (en) * 2016-11-22 2020-10-21 Alloplex Biotherapeutics Allogenic tumor cell vaccine
US11185586B2 (en) 2016-11-22 2021-11-30 Alloplex Biotherapeutics, Inc. Allogeneic tumor cell vaccine

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DK0904786T3 (en) * 1997-08-22 2005-03-21 Science Park Raf S P A Tumor vaccination using autologous or HLA-related antigen presenting cells (APC) transduced with a tumor antigen and a foreign antigen that may elicit an immune response

Also Published As

Publication number Publication date
WO2003045428A3 (en) 2003-12-18
WO2003045428A2 (en) 2003-06-05

Similar Documents

Publication Publication Date Title
IL159344A0 (en) Quinuclidines-substituted-multicyclic-heteroaryls for the treatment of disease
HUP0204250A3 (en) Use of hiv-protein or -polynucleotide for vaccine produce
AU2001282873A1 (en) Quinuclidine-substituted aryl compounds for treatment of disease
AU2003219690A1 (en) Fused bicyclic-n-bridged-heteroaromatic carboxamides for the treatment of disease
AU2002257936A1 (en) Methods of well treatment
AU2001227837A1 (en) Novel treatment for eye disease
AU2001284646A1 (en) Quinuclidine-substituted heteroaryl moieties for treatment of disease
AU2001282875A1 (en) Quinuclidine-substituted heteroaryl moieties for treatment of disease
HUP0300099A3 (en) Vaccine for the treatment of artherosclerosis
AU2001284645A1 (en) Quinuclidine-substituted aryl compounds for treatment of disease
AU2002356763A1 (en) Use of a technically modified cell as a vaccine for treating tumoral disease
AU2002335061A1 (en) Hookworm vaccine
AU2003229346A1 (en) Use of a vaccine for active immunization against cancer
GB0209254D0 (en) Preparation for the relief of disease
AU2003298725A8 (en) Preparation of metallotexaphyrins
GB0201025D0 (en) The treatment of degenerative diseases
AU2003239773A1 (en) Preparation of vaccines
AU2003213700A1 (en) Immunogens for treatment of neoplastic and infectious disease
AU2001262520A1 (en) Combined preparation for the treatment of neoplasic diseases
GB0100092D0 (en) Treatment of degenerative diseases
EP1437347A3 (en) Process for the preparation of arylvinyl halides and aralkinyl compounds
AU2002241776A1 (en) Treatment of disease by inducing cell apoptosis
AU2003243215A1 (en) Treatment for human papillomavirus
AU2002322013A1 (en) Therapeutic dna vaccination
AU2002338794A1 (en) Use of mannosamine derivatives for the stimulation of neurite growth

Legal Events

Date Code Title Description
MK6 Application lapsed section 142(2)(f)/reg. 8.3(3) - pct applic. not entering national phase